Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.
Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD.
Bednasz CJ, et al.
Ther Drug Monit. 2017 Dec;39(6):596-603. doi: 10.1097/FTD.0000000000000443.
Ther Drug Monit. 2017.
PMID: 29135907
Free PMC article.